| Literature DB >> 21206810 |
Vinay Gupta1, Rakesh Magon, B P Mishra, G B S Sidhu, Ranjiv Mahajan.
Abstract
Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important.Entities:
Keywords: malignant syndrome; neuroleptic; risk factors
Year: 2003 PMID: 21206810 PMCID: PMC2951537
Source DB: PubMed Journal: Indian J Psychiatry ISSN: 0019-5545 Impact factor: 1.759